As of June 21, 2025, Peak Pharmaceuticals Inc (PKPH) reports a Current Ratio of 0.36.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Peak Pharmaceuticals Inc's Current Ratio
Over recent years, Peak Pharmaceuticals Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2022-09-30 | 0.36 |
| 2021-09-30 | 0.97 |
| 2020-09-30 | 0.00 |
| 2019-09-30 | 0.00 |
| 2018-09-30 | 0.01 |
This slight downward trend highlights how Peak Pharmaceuticals Inc manages its short-term assets and liabilities over time.
Comparing Peak Pharmaceuticals Inc's Current Ratio to Peers
To better understand Peak Pharmaceuticals Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Peak Pharmaceuticals Inc (PKPH) | 0.36 |
| Forward Pharma A/S (FWP) | 117.44 |
| Constellation Pharmaceuticals Inc (CNST) | 14.05 |
| PZ Wind Down Inc (PZRXQ) | 7.99 |
| Phio Pharmaceuticals Corp (PHIO) | 5.63 |
| Globeimmune Inc (GBIM) | 2.62 |
Compared to its competitors, Peak Pharmaceuticals Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.